Davie, FL – Privately owned Contract Development and Manufacturing Organization (CDMO) PharmaTech LLC has announced that it has undertaken significant expansion of its current state of the art research, development and manufacturing facility outside of Fort Lauderdale, Florida. The investment is part of PharmaTech’s strategy to increase its manufacturing capacity as well as to support its clients’ growing research and development and generic drug development needs. The facility expansion will bring an additional 50,000 square feet of space for increased solids, liquid and nanotechnology formulation and manufacturing capabilities.
PharmaTech’s current expansion is reflective of its position as the fastest growing Contract Development Manufacturing Organization (CDMO) in South Florida. The expanded manufacturing facilities is expected to lead to creation of more than forty-five new jobs over the next year in the areas of Quality Assurance, Project Management, Research and Development, Manufacturing and Logistics. Along with the expansion to its laboratory, manufacturing and operations facilities, PharmaTech will be expanding office space located at its headquarters as well as moving its warehousing and distribution operations offsite to multiply its capabilities in the area of logistics.
“We’re excited that our facility expansion will allow us greater capacity, capabilities and flexibility to meet the needs of our continually growing client base,” said PharmaTech Chief Executive Officer, Raidel Figueroa.
About PharmaTech LLC
PharmaTech LLC, based near Fort Lauderdale in Davie, Florida, has experienced rapid growth since its inception in 2009 and has quickly established itself as an industry leading full service Contract Development and Manufacturing Organization (CDMO). PharmaTech provides turnkey Research and Formulation Development services for solid, liquid and topical Rx, OTC and Supplement products to its clients worldwide. PharmaTech focuses on Private Labeling Solutions; Standard Packaging and Custom Packaging Configurations; Development, Submission Filing and Commercialization of ANDAs; Logistics Coordination and Worldwide Delivery Services.
To learn more about PharmaTech’s expanded capabilities, please contact:
David Beem, Chief Operating Officer
4131 SW 47th Avenue, Suite 1403